ACZONE
ACZONE
Approved
DIN Number
02281074
Drug Class
Human
Market Date
Oct 21, 2011
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02281074
AIG Number0106115002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D10AX05 DAPSONE
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
DAPSONEActive
Strength: 5 % / W/W
Monograph: DAPSONE